Scientists hunt for clues to chemo allergies in kids with leukemia
NCT ID NCT07529223
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at why some people with acute lymphoblastic leukemia (ALL) have severe allergic reactions to the drug asparaginase. Researchers will collect blood cells from 20 patients and test them in the lab to see if certain immune cells (T cells) become overactive. The goal is to create a test that can predict who is at risk, so treatment can be made safer.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
APHM
Marseille, 13354, France
-
CHU de Nice
Nice, CHU de Nice, 06003, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Fighting sedentary time in young cancer patients: a digital intervention put to the test
- Can targeted drugs blinatumomab and venetoclax improve outcomes for childhood leukemia?
- Supercharged immune cells take aim at cancer and viruses in one shot
- Massive global study aims to uncover why young cancer patients in poorer nations fare worse
- New antibody takes aim at Hard-to-Treat blood cancers
- New hope for kids with aggressive leukemia relapse